IP Verse

Il-17 A/F Heterologous Polypeptides And Therapeutics Uses Thereof

Patent No. EP2784084 (titled "Il-17 A/F Heterologous Polypeptides And Therapeutics Uses Thereof") was filed by Genentech on Jun 2, 2004. The application was issued on Oct 4, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELI LILLY GESELLSCHAFTAug 30, 2021INGHAM
UCB BIOPHARMAApr 23, 2020J A KEMP
MERCK PATENTApr 22, 2020BIRD & BIRD
ELI LILLY AND LILLY DEUTSCHLANDMar 16, 2020INGHAM
NOVARTISJul 24, 2019CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2784084

GENENTECH
Application Number
EP14163686A
Filing Date
Jun 2, 2004
Status
Patent Maintained As Amended
Sep 1, 2023
Publication Date
Oct 4, 2023
External Links
Slate, Register , Google Patents